Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-20-002862

Chief Financial Officer bought 142,000 shares at $2.04 ($289,680)

From the SEC's structured data for this filing

Trades in this filing

Downs Christopher · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-08-24 Purchase : show line 1 in the form +142,000 $2.04 $289,680 142,000 D
Open-market purchases · 142,000 sh · avg $2.04 · $289,680
Loading xslF345X03/ownership.xml…